Summary of Key Points Core Viewpoint The report discusses the completion and changes of certain fundraising projects by Broadcom Integrated Circuit (Shanghai) Co., Ltd., including the allocation of surplus funds to new projects, specifically focusing on the development of edge AI processor products and solutions. Group 1: Fundraising Overview - In 2019, the company raised approximately RMB 646 million through an initial public offering, with a net amount of about RMB 603 million allocated for specific projects [1] - As of June 20, 2025, the company has invested RMB 53.26 million in the "Standard Protocol Wireless Interconnection Product Technology Upgrade Project" and "Smart Home Entry Product R&D and Industrialization Project," achieving an investment progress of 88.31% [2] - The company has completed the "R&D Center Construction Project," with a total investment of RMB 24.44 million, of which RMB 16.47 million has been utilized, resulting in a surplus of RMB 10.80 million [3][6] Group 2: Project Changes and Adjustments - The company plans to adjust the investment structure of the "Smart Transportation and Intelligent Driving R&D and Industrialization Project," reducing the investment by RMB 21.04 million and reallocating it to the new "Edge AI Processor Product and Solution R&D Project" [4][5] - The total investment for the new project is estimated at RMB 45.83 million, with RMB 31.85 million sourced from the adjusted funds [12][13] - The completion date for the "Smart Transportation and Intelligent Driving R&D and Industrialization Project" has been extended to June 30, 2026, to accommodate the changes [5][11] Group 3: New Project Details - The new project focuses on developing low-power, high-performance edge AI chips and solutions, targeting smart home, wearable devices, and automotive electronics [12][14] - The project aims to create a comprehensive technology system, including hardware, algorithms, and software, to enhance the company's competitive edge in the AIoT market [15][16] - The company has a strong R&D team, with 86.52% of its workforce dedicated to research, ensuring effective project execution [18] Group 4: Regulatory Compliance and Approval - The adjustments to the fundraising projects have been reviewed and approved by the company's board and supervisory committee, pending shareholder approval [21] - The company has established a dedicated account for managing the raised funds, ensuring compliance with regulatory requirements [20]

Company Overview - Baolingbao is a leading company in the functional sugar sector, focusing on the research, production, and sales of prebiotics, sugar-reducing sweeteners, and dietary fibers, with an annual comprehensive production capacity exceeding 500,000 tons and over 2,000 active customers [2][3] - The company has recently appointed Mr. Wang Qiang as the general manager, who has extensive management experience in food raw material companies [2] Performance and Growth Strategy - In 2024, Baolingbao is expected to achieve a significant profit increase through proactive adjustments in product structure and marketing strategies, while also adjusting revenue [2] - The company has set ambitious performance targets for 2025-2027, with net profit goals of at least 170 million yuan in 2025, a cumulative total of at least 382 million yuan for 2025-2026, and at least 647 million yuan for 2025-2027 [2] Industry Trends - The functional sugar industry is experiencing rapid growth driven by demographic changes, consumer preferences, and policy guidance, with a shift from traditional sweeteners to healthier alternatives [3] - The demand for sugar substitutes and functional sugars is on the rise, indicating a favorable market environment for Baolingbao's products [3] Product Focus - Baolingbao is the largest producer of isomaltooligosaccharides globally, with prebiotics being the primary source of gross profit in 2024 [4] - The company is also a pioneer in the industrial production of erythritol and is expanding its market share internationally, with erythritol sales revenue increasing by 52.58% year-on-year in 2024 [4] Future Prospects - The company plans to launch several new products utilizing synthetic biology technology in the next 1-2 years, including new capacities for erythritol and a 20,000-ton expansion project for allulose starting in March 2025 [5] - Baolingbao's revenue projections for 2025-2027 are 2.574 billion yuan, 2.794 billion yuan, and 3.069 billion yuan, respectively, with net profits of 170 million yuan, 221 million yuan, and 274 million yuan [5]

Market Overview - A-shares experienced a collective rise on June 30, with the Shanghai Composite Index up by 0.59%, the Shenzhen Component Index up by 0.83%, and the ChiNext Index up by 1.35% [1][2][3] - Over 4,000 stocks in the market closed in the green, indicating a broad-based rally [1] Performance Metrics - The Shanghai Composite Index recorded a cumulative increase of 2.76% in the first half of the year, while the North Star 50 Index surged nearly 40% [2] Sector Performance - The military equipment sector showed strong performance, with stocks like Changcheng Military Industry, Hunan Tianyan, and Beifang Navigation hitting the daily limit [5] - Other active sectors included gaming, brain-computer interfaces, and photovoltaics, while the financial sector underperformed [5] Capital Flow - Main capital inflows were observed in the defense, media, and electronics sectors, while there were net outflows from non-bank financials, banks, and non-ferrous metals [5] - Notable net inflows included Chengfei Integration (6.95 billion), Dongxin Peace (5.15 billion), and Rongfa Nuclear Power (5.13 billion) [5] - Conversely, Hengbao Co., Tianfeng Securities, and Dongfang Fortune experienced significant net outflows of 7.32 billion, 6.62 billion, and 5.33 billion respectively [5] Institutional Insights - Dongfang Securities highlighted the ongoing development of AI and the expanding potential in the gaming sector [7] - Boxin Securities projected that the market may continue to rebound in the second half of the year, potentially reaching above 3,600 points if trading volume supports the trend [9] - Guocheng Investment noted that the index has completed a bottoming process and may strongly approach 3,700 points in the latter half of the year [9]

| 证券代码：601162 证券简称：天风证券 公告编号：2025-035 | | | | | --- | --- | --- | --- | | 天风证券股份有限公司 | | | | | 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 | | | | | 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 | | | | | 重要内容提示： | | | | | 本次会议是否有否决议案：无 | ? | | | | 一、 会议召开和出席情况 | | | | | 06 27 (一)股东会召开的时间：2025 年 月 日 | | | | | (二)股东会召开的地点：湖北省武汉市武昌区中北路 217 号天风大厦 3 楼会议室 | | | | | (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | | | | | 份总数的比例（%） 38.0461 | | | | | (四)表决方式是否符合《公司法》及《公司章程》的规定，股东会主持情况等。 | | | | | 本次股东会由公司董事会召集，会议由董事长庞介民先生主持，会议的召集、 | | | | | 召开及表决方式符 ...

Group 1 - The State Council, led by Li Qiang, held a meeting to discuss the implementation of the national science and technology conference spirit to accelerate the construction of a strong technology nation [1] - The central bank aims to enhance support for technological innovation and boost consumption while exploring institutional arrangements to maintain capital market stability [2] - The Shanghai and Shenzhen stock exchanges announced an adjustment of the price fluctuation limit for risk-warning stocks on the main board from 5% to 10% [3] Group 2 - Xiaomi's official account reported that within 18 hours of opening sales, the Xiaomi YU7 has surpassed 240,000 units in locked orders [4] - The domestically produced GLP-1 weight loss drug, Masitide, has been approved for long-term weight control in adults with obesity or overweight [5] - Tianfeng Securities noted that the company's price-to-book ratio is higher than the industry median [6] - Aijian Group, which has seen three consecutive trading limit increases, stated that it has not engaged in any stablecoin-related business [6] - Times Wan Heng, which has seen two consecutive trading limit increases, focuses on the research, production, and sales of new energy batteries [6] - Jinsong New Materials is under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure laws [6]

证券代码：601162 证券简称：天风证券 公告编号：2025-033号 天风证券股份有限公司 股票交易异常波动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ●天风证券股份有限公司（以下简称"公司"）股票交易于2025年6月25日、 6月26日、6月27日连续三个交易日内日收盘价格涨幅偏离值累计达到20%，属于 《上海证券交易所交易规则》规定的异常波动情形。 ●经公司自查并向控股股东及其一致行动人书面询证，截至本公告披露日， 不存在应披露而未披露的重大事项。 一、股票交易异常波动的具体情况 公司股票交易于2025年6月25日、6月26日、6月27日连续三个交易日内日收 盘价格涨幅偏离值累计达到20%，属于《上海证券交易所交易规则》规定的异常 波动情形。 二、公司关注并核实的相关情况 （一）公司经营情况 经公司自查，截至本公告披露日，公司经营活动正常，公司内外部经营环境 未发生重大变化，不存在应披露而未披露的重大事项。 （二）重大事项情况 经公司自查并向公司控股股东及其一致行动人书面询证，确认截至本公告披 ...

天风证券股份有限公司（以下简称"公司"）于2025年6月26日收到与收益 相关的政府补贴550万元，占公司2024年度经审计的归属于上市公司股东净利润 绝对值的18.51%。 二、补贴的类型及其对公司的影响 根据《企业会计准则》等有关规定，公司已确认上述补贴事项并划分类型。 上述政府补贴预计将对公司利润产生一定的积极影响，具体的会计处理以及对公 司损益的影响情况尚须以审计机构年度审计确认后的结果为准，敬请广大投资者 注意投资风险。 特此公告。 天风证券股份有限公司董事会 证券代码：601162 证券简称：天风证券 公告编号：2025-034号 天风证券股份有限公司 关于获得政府补贴的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、获得补贴的基本情况 2025 年 6 月 28 日 ...

关于天风证券股份有限公司 股票交易异常波动问询函的回函 天风证券股份有限公司： 你公司报来的《关于天风证券股份有限公司股票交易异 常波动有关事项的问询函》已收悉，本公司作为你公司的控 股股东，现就有关情况回复如下： 除你公司已披露事项以外，截止目前，本公司及相关方 不存在影响你公司股票交易异常波动的重大事项；本公司及 相关方不存在其他应披露而未披露的重大信息，包括但不限 于重大资产重组、发行股份、重大交易类事项、业务重组、 股份回购、股权激励、破产重整、重大业务合作、引进战略 投资者等重大事项。 特此函复。 湖北宏泰集团有限公司 2025 年 6 月 27 日 关于天风证券股份有限公司股票交易异常波动 有关事项的回函 在你公司此次股票交易异常波动期间(2025 年 6 月 25 日、6 月 26 日、6 月 27 日)，不存在买卖你公司股票的情况。 天风证券股份有限公司: 你公司《关于天风证券股份有限公司股票交易异常波动 有关事项的问询函》已收悉,现就有关问题回复如下: 一、除你公司已披露事项以外,截止目前,我公司不存 在涉及你公司应披露而未披露的事项,不存在筹划涉及你公 司的重大资产重组、股份发行、重大交易 ...

日 | 君泽君津师事务所 TIT JunZeJun Law Offices 上海市杨高南路 729 号陆家嘴世纪金融广场一号楼 40 层 邮编:200127 电话:(8621)61060889 传真:(8621)61060890 40 Floor, Lujiazui Century Financial Plaza, No.729 South Yanggao Road, Shanghai 200127, P.R.China Tel: (8621) 61060889 / Fax: (8621) 61060890 北京市君泽君(上海)律师事务所 关于天风证券股份有限公司 2024年年度股东会的 律师见证意见 致:天风证券股份有限公司 北京市君泽君(上海)律师事务所(以下简称"君泽君"或"本所")接受天风 证券股份有限公司(以下简称"公司")委托,委派律师出席公司于 2025年 6 月 27日召开的 2024年年度股东会(以下简称"本次股东会"),并根据《中华人民 共和国证券法》(以下简称"《证券法》")、《中华人民共和国公司法》(以下 简称"《公司法》")及《上市公司股东会规则》等法律、法规及规范性文件和《天 风证 ...

证券代码：601162 证券简称：天风证券 公告编号：2025-035 (二)股东会召开的地点：湖北省武汉市武昌区中北路 217 号天风大厦 3 楼会议室 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 4,288 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 3,832,757,010 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 38.0461 | (四)表决方式是否符合《公司法》及《公司章程》的规定，股东会主持情况等。 天风证券股份有限公司 2024年年度股东会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 (一)股东会召开的时间：2025 年 06 月 27 日 本次股东会由公司董事会召集，会议由董事长庞介民先生主持，会议的召集、 召开及表决方式符合《公司法》及《公司章程》的规定。 (五 ...